Currently, there are no approved vaccines for Marburg virus disease.

The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.

Serosurveys have expanded our understanding of infectious diseases in Africa, revealing the true burden of pathogens beyond reported outbreaks. These studies have uncovered silent epidemics of ...

Sabin’s vaccine development efforts, including clinical trials, are becoming increasingly critical as Marburg outbreaks grow in frequency, underscoring the urgent need for vaccines to protect ...